Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms.
about
Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)-A59 from mouse liver and identification of a nonfunctional, homologous protein in MHV-resistant SJL/J miceMutational analysis of the virus and monoclonal antibody binding sites in MHVR, the cellular receptor of the murine coronavirus mouse hepatitis virus strain A59Selective tropism of a neurotropic coronavirus for ependymal cells, neurons, and meningeal cells.Production by mixed lymphocyte cultures of a type II interferon able to protect macrophages against virus infectionLoss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity.In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice.Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice.Comparison of Track XI fluorometric immunoassay with Bio-EnzaBead enzyme-linked immunosorbent assay for detection of serum antibody to mouse hepatitis virusMacrophage interleukin-6 and tumour necrosis factor-alpha are induced by coronavirus fixation to Toll-like receptor 2/heparan sulphate receptors but not carcinoembryonic cell adhesion antigen 1a.In vivo and in vitro models of demyelinating disease: efficiency of virus spread and formation of infectious centers among glial cells is genetically determined by the murine host.Persistent infection with mouse hepatitis virus 3 in mouse lymphoid cell lines.Murine viral hepatitis involves NK cell depletion associated with virus-induced apoptosis.Toll-like receptor-2 exacerbates murine acute viral hepatitis.16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection
P2860
Q28508287-1C89D74C-0744-4C03-81F4-70EA3D59EE41Q33782330-71C1481D-56D9-4686-B69F-FC2B8F25AF8BQ33928217-F5F668BA-8786-4D56-8810-E129C2D0A95FQ34412612-BA5C65BF-023E-4DAE-9D92-425E9E974F1CQ35863381-2C0D08CE-D5F6-4910-A0F3-FC4FE0D2A4CBQ36334005-11987B63-A7A1-4E49-8DB9-C48C9E2E85D9Q36345740-1EC2FAC5-EBAB-4C3B-BEBD-DBB469D17821Q37145489-CAB46B37-B37E-4C44-9388-DE172B07C451Q39796211-CA3AB352-4E15-45AA-BB20-BB67A00F1EE9Q40129000-0B8DCE57-4201-442D-81A5-1838E663CFA3Q40178766-8B5AAD79-44DA-42FA-B070-81DD2AE00A32Q40545629-3E8C85F1-BCEC-4B02-BA78-2B932C558DC2Q40641510-8FF36374-2709-4938-A63B-0C4D9589DF52Q41015489-37BA660A-8BF0-484B-8865-9D41C6773710
P2860
Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年学术文章
@wuu
1975年学术文章
@zh-cn
1975年学术文章
@zh-hans
1975年学术文章
@zh-my
1975年学术文章
@zh-sg
1975年學術文章
@yue
1975年學術文章
@zh
1975年學術文章
@zh-hant
name
Immunopathology of mouse hepat ...... nity in resistance mechanisms.
@en
Immunopathology of mouse hepat ...... nity in resistance mechanisms.
@nl
type
label
Immunopathology of mouse hepat ...... nity in resistance mechanisms.
@en
Immunopathology of mouse hepat ...... nity in resistance mechanisms.
@nl
prefLabel
Immunopathology of mouse hepat ...... nity in resistance mechanisms.
@en
Immunopathology of mouse hepat ...... nity in resistance mechanisms.
@nl
P2093
P1476
Immunopathology of mouse hepat ...... nity in resistance mechanisms.
@en
P2093
Le Prevost C
Levy-Leblond E
Virelizier JL
P304
P407
P433
P577
1975-01-01T00:00:00Z